GSK Pushes 3rd Circ. To Rehear Lamictal Pay-For-Delay Suit
GlaxoSmithKline PLC asked the full Third Circuit on Monday to review a panel ruling reviving an antitrust class action accusing the drugmaker of paying off Teva Pharmaceutical Industries Ltd. to delay...To view the full article, register now.
Already a subscriber? Click here to view full article